Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Liver Cirrhosis

Free Subscription Articles published in J Hepatol Retrieve available abstracts of 147 articles: HTML format Text format

Single Articles

January 2010
1. FRANCOZ C , Glotz D, Moreau R, Durand F, et al
   The evaluation of renal function and disease in patients with cirrhosis.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
2. TAURA P , Fuster J, Mercadal J, Martinez-Palli G, et al
   The use of beta-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. FONTANA RJ
   Entecavir in decompensated HBV cirrhosis: The future is looking brighter.
   J Hepatol. 2009.
   PubMed     Text format     Related articles   
   
   
   
4. TESTRO AG , Gow PJ, Angus PW, Wongseelashote S, et al
   Effects of antibiotics on expression and function of Toll-like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosis.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. SHIM JH , Lee HC, Kim KM, Lim YS, et al
   Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. SHERMAN M
   Vinyl chloride and the liver.
   J Hepatol. 2009;51:1074-81.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
7. GRASSO A
   Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: A clarification.
   J Hepatol. 2009.
   PubMed     Text format     Related articles   
   
   
   
8. WU KT , Yang JF, Chuang WL, Yu ML, et al
   Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issues.
   J Hepatol. 2009.
   PubMed     Text format     Related articles   
   
   
   
9. PAPATHEODORIDIS GV , Chrysanthos N, Cholongitas E, Pavlou E, et al
   Thrombotic risk factors and liver histologic lesions in non-alcoholic fatty liver disease.
   J Hepatol. 2009;51:931-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
10. WIEST R , Schoelmerich J
    Secondary peritonitis in cirrhosis: "Oil in fire"
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
11. SORIANO G , Castellote J, Alvarez C, Girbau A, et al
    Secondary bacterial peritonitis in cirrhosis: A retrospective study of clinical and analytical characteristics, diagnosis and management.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MERKEL C , Bolognesi M, Berzigotti A, Amodio P, et al
    Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. TSOCHATZIS EA , Gurusamy KS, Gluud C, Burroughs AK, et al
    Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
14. BEUERS U , Trauner M
    Ursodeoxycholic acid in primary biliary cirrhosis: Reply.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
15. DOMENICALI M , Caraceni P, Giannone F, Baldassarre M, et al
    A novel model of CCl(4)-induced cirrhosis with ascites in the mouse.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
16. SAMRI A , Roque-Afonso AM, Beran O, Tateo M, et al
    Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. MALIK R , Mookerjee RP, Jalan R
    Infection and inflammation in liver failure: two sides of the same coin.
    J Hepatol. 2009;51:426-9.
    PubMed     Text format     Related articles   
    
    
    
18. NOZAKI Y , Fujita K, Yoneda M, Wada K, et al
    Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.
    J Hepatol. 2009;51:548-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
19. DE NICOLA S , Aghemo A, Rumi MG, Colombo M, et al
    HCV genotype 3: An independent predictor of fibrosis progression in chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
20. CARRION JA , Navasa M, Forns X
    Antiviral therapy in HCV-infected cirrhotic patients awaiting liver transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
21. MCPHERSON S , Jonsson JR, Cowin GJ, O'Rourke P, et al
    Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
    J Hepatol. 2009;51:389-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. TORDJMAN J , Poitou C, Hugol D, Bouillot JL, et al
    Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status.
    J Hepatol. 2009;51:354-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
23. GRASSO A , Malfatti F, Leo PD, Martines H, et al
    Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. KADAYIFCI A , Bass NM
    Coronary artery disease in NASH-related cirrhosis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
25. MANOLAKOPOULOS S , Triantos C, Theodoropoulos J, Vlachogiannakos J, et al
    Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. KALAITZAKIS E , Bjornsson E
    Coronary artery disease in liver cirrhosis: Does the aetiology of liver disease matter?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    June 2009
27. GARCIA-PAGAN JC , Valla DC
    Portal vein thrombosis: A predictable milestone in cirrhosis?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
28. MONTAGNESE S , Middleton B, Skene DJ, Morgan MY, et al
    Sleep-wake patterns in patients with cirrhosis: All you need to know on a single sheet A simple sleep questionnaire for clinical use.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. NIEMCZYK M , Krawczyk M, Paczek L
    Antiviral therapy preceding liver transplantation in HCV cirrhosis - Still too many doubts.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
30. LI Y , Chang M, Abar O, Garcia V, et al
    Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. EUROPEAN ASSOCIATION FOR THE S
    EASL Clinical Practice Guidelines: Management of cholestatic liver diseases.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
32. LI C , Kong Y, Wang H, Wang S, et al
    Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis.
    J Hepatol. 2009;50:1174-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. BOTTERO J , Lacombe K, Guechot J, Serfaty L, et al
    Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.
    J Hepatol. 2009;50:1074-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. OKIYAMA W , Tanaka N, Nakajima T, Tanaka E, et al
    Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress.
    J Hepatol. 2009;50:1236-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. BEDOSSA P , Carrat F
    Liver fibrosis: screening is not staging.
    J Hepatol. 2009;50:1268-9.
    PubMed     Text format     Related articles   
    
    
    May 2009
36. PERUT V , Conti F, Scatton O, Soubrane O, et al
    Might physicians be restricting access to liver transplantation for patients with alcoholic liver disease?
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. CAZZANIGA M , Dionigi E, Gobbo G, Fioretti A, et al
    The systemic inflammatory response syndrome in cirrhotic patients: Relationship with their in-hospital outcome.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. LA MURA V , Abraldes JG, Raffa S, Retto O, et al
    Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. TRIPODI A , Chantarangkul V, Primignani M, Dell'era A, et al
    Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INR(liver)) can help to implement the INR(liver) for the calculation of the MELD score.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. ZHANG S , Wang J, Liu Q, Harnish DC, et al
    Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. MERKEL C
    A short cut to predict the clinical response to beta-blocker therapy in cirrhosis?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
42. SELMI C , Gershwin ME
    The retroviral myth of primary biliary cirrhosis: Is this (finally) the end of the story?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
43. ARGO CK , Northup PG, Al-Osaimi AM, Caldwell SH, et al
    Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
44. ZOCCO MA , Stasio ED, Cristofaro RD, Novi M, et al
    Thrombotic risk factors in patients with liver cirrhosis: Correlation with MELD scoring system and portal vein thrombosis development.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. CASTERA L , de Ledinghen V, Couzigou P
    Transient elastography vs. blood tests for the diagnosis of cirrhosis: An empiric victory.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
46. HU PF , Chen H, Zhong W, Lin Y, et al
    Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. TRAPPOLIERE M , Caligiuri A, Schmid M, Bertolani C, et al
    Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
48. ADORINI L
    Vitamin D receptor polymorphisms in primary biliary cirrhosis: A functional connection?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
49. MELLING N , Hohenberger W, Yedibela S
    Opisthorchiasis mimicking primary biliary cirrhosis as an indication for liver transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. HENRIKSEN JH , Moller S
    WITHDRAWN: Kowalski HJ, Abelmann WH. The cardiac output in Laennec's cirrhosis [J Clin Invest 1953;32:1025-1033].
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. CALES P , Boursier J, Oberti F
    Ultrasonographic elastometry vs. blood tests for the diagnosis of cirrhosis: A Pyrrhic victory?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
52. CHRISTENSEN E
    Portal hypertension and development of hepatocellular carcinoma: Factors influencing significance in prognostic models.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
53. RIPOLL C , Groszmann RJ, Garcia-Tsao G, Bosch J, et al
    Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. TANAKA A , Nezu S, Uegaki S, Kikuchi K, et al
    Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. FERNANDEZ M , Semela D, Bruix J, Colle I, et al
    Angiogenesis in liver disease.
    J Hepatol. 2009;50:604-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. BLOMME B , Van Steenkiste C, Callewaert N, Van Vlierberghe H, et al
    Alteration of protein glycosylation in liver diseases.
    J Hepatol. 2009;50:592-603.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
57. TSAI MH , Peng YS, Chen YC, Lien JM, et al
    Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. MARTINELLI I , Primignani M, Aghemo A, Reati R, et al
    High levels of factor VIII and risk of extra-hepatic portal vein obstruction.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. ROCHE B , Samuel D
    Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
60. TSAI MC , Chen CH, Lee CM, Chen YT, et al
    The role of HBV genotype, core promoter and precore mutations in advanced liver disease in renal transplant recipients.
    J Hepatol. 2009;50:281-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
61. SAMUEL D
    MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. SALMON-CERON D , Rosenthal E, Lewden C, Bouteloup V, et al
    Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 study.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. SEEFF LB
    Are herbals as safe as their advocates believe?
    J Hepatol. 2009;50:13-6.
    PubMed     Text format     Related articles   
    
    
    
64. BEDOSSA P , Carrat F
    Liver biopsy: the best, not the gold standard.
    J Hepatol. 2009;50:1-3.
    PubMed     Text format     Related articles   
    
    
    
65. CALES P , Laine F, Boursier J, Deugnier Y, et al
    Comparison of blood tests for liver fibrosis specific or not to NAFLD.
    J Hepatol. 2009;50:165-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
66. CARRION JA , Martinez-Bauer E, Crespo G, Ramirez S, et al
    Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. JOHAL H , Marie Scott G, Jones R, Camaris C, et al
    Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. FICKERT P , Trauner M
    When lightning strikes twice: The plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. BERG PA
    Autoimmunity in primary biliary cirrhosis: An alternative view at initiation and function of anti-mitochondrial autoantibodies.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
70. CASTERA L , Forns X, Alberti A
    Interpreting liver stiffness in the cirrhotic range: What are we measuring?
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
71. BIOULAC-SAGE P , Couffinhal T, Foucher J, Balabaud CP, et al
    Interpreting liver stiffness in the cirrhotic range.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
72. BERRES ML , Papen S, Pauels K, Schmitz P, et al
    A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. NAHON P , Kettaneh A, Tengher-Barna I, Ziol M, et al
    Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
    J Hepatol. 2008;49:1062-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
74. VARCHETTA S , Oliviero B, Francesca Donato M, Agnelli F, et al
    Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. SORRENTINO P , D'Angelo S, Ferbo U, Micheli P, et al
    Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. BONEKAMP S , Kamel I, Solga S, Clark J, et al
    Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. WEDEMEYER I , Bechmann LP, Odenthal M, Jochum C, et al
    Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. BOSCH J
    Towards the non-invasive diagnosis of cirrhosis: The nuts-cirrhosis connection.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    October 2008
79. CASTERA L , Bail BL, Roudot-Thoraval F, Bernard PH, et al
    Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. STICKEL F , Droz S, Patsenker E, Bogli-Stuber K, et al
    Severe hepatotoxicity following ingestion of Herbalife((R)) nutritional supplements contaminated with Bacillus subtilis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. GACHE P , Hadengue A
    Baclofen improves abstinence in alcoholic cirrhosis: Still better to come?
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. ROSENBAUM J
    Vitamin A-guided siRNAs targeting a collagen chaperone can reverse experimental cirrhosis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. BEUERS U , Oude-Elferink RP
    New light on anion exchangers in primary biliary cirrhosis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
84. FUJITA T
    Probiotics for patients with liver cirrhosis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
85. POUPON R , Ping C, Chretien Y, Corpechot C, et al
    Genetic factors of susceptibility and of severity in primary biliary cirrhosis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. STADLBAUER V , Mookerjee RP, Jalan R
    Probiotics for patients with liver cirrhosis: Reply.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
87. DE FRANCHIS R
    Non-invasive (and minimally invasive) diagnosis of oesophageal varices.
    J Hepatol. 2008;49:520-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. MACIAS J , Recio E, Vispo E, Rivero A, et al
    Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
89. NIKKILA K , Nissinen MJ, Gylling H, Isoniemi H, et al
    Serum sterols in patients with primary biliary cirrhosis and acute liver failure before and after liver transplantation.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. DE LIMA VM , Oliveira CP, Alves VA, Chammas MC, et al
    A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. TEUBER G , Schafer A, Rimpel J, Paul K, et al
    Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. YUEN MF , Tanaka Y, Fong DY, Fung J, et al
    Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
93. STOLZE LARSEN F
    Branched-chain amino acids antagonism in patients with cirrhosis and a simulated upper GI bleeding.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
94. ZIPPRICH A , Loureiro-Silva MR, Jain D, D'Silva I, et al
    Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
95. PAGGI S , Colli A, Fraquelli M, Vigano M, et al
    A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: A comparison using histology with internal-external validation.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. IWAISAKO K , Hatano E, Taura K, Nakajima A, et al
    Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. SELMI C , Zuin M, Eric Gershwin M
    The unfinished business of primary biliary cirrhosis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. ZACHARAKIS G , Koskinas J, Kotsiou S, Tzara F, et al
    The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: Association with liver disease progression. A prospective cohort study.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. DOUGLASS A , Wallace K, Parr R, Park J, et al
    Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury.
    J Hepatol. 2008;49:88-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
100. KADAYIFCI A , Tan V, Ursell PC, Merriman RB, et al
     Clinical and pathologic risk factors for atherosclerosis in cirrhosis: A comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. BOGDANOS D , Pusl T, Rust C, Vergani D, et al
     Primary biliary cirrhosis following lactobacillus vaccination for recurrent vaginitis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. FLEMING KM , Aithal GP, Solaymani-Dodaran M, Card TR, et al
     Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: A general population-based study.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. HALANGK J , Sarrazin C, Neumann K, Puhl G, et al
     Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. OLDE DAMINK SW , Jalan R, Deutz NE, Hayes PC, et al
     Protein synthesis is severely diminished following a simulated upper GI bleed in patients with cirrhosis.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
105. MATEI V , Rodriguez-Vilarrupla A, Deulofeu R, Garcia-Caldero H, et al
     Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl(4) cirrhotic rats.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. FUJITA T
     Is bacterial DNA a surrogate marker of bacterial translocation in cirrhosis?
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
107. FRANCES R , Such J
     Bacterial DNA translocation in patients with cirrhosis: Reply.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
108. CASTERA L , Forns X, Alberti A
     Non-invasive evaluation of liver fibrosis using transient elastography.
     J Hepatol. 2008;48:835-47.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. SEBASTIANI G , Alberti A
     Implementing non-invasive markers for liver fibrosis in clinical practice.
     J Hepatol. 2008;48:880-1.
     PubMed     Text format     Related articles   
     
     
     April 2008
110. SCHWETTMANN L , Wehmeier M, Jokovic D, Aleksandrova K, et al
     Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. REBOUISSOU S , Couchy G, Libbrecht L, Balabaud C, et al
     The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. COLL M , Genesca J, Raurell I, Rodriguez-Vilarrupla A, et al
     Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. O'BEIRNE J , Burroughs AK
     Incidence of adrenal dysfunction in cirrhosis.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
114. PEFFAULT DE LATOUR R , Ribaud P, Robin M, Valla D, et al
     Allogeneic hematopoietic cell transplant in HCV-infected patients.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2008
115. ASSY N , Pruzansky Y, Gaitini D, Shen Orr Z, et al
     Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. STADLBAUER V , Mookerjee RP, Hodges S, Wright GA, et al
     Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. YANG YY , Lee KC, Huang YT, Wang YW, et al
     Effects of N-acetylcysteine administration in hepatic microcirculation of rats with biliary cirrhosis.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. KIMURA K , Nagaki M, Kakimi K, Saio M, et al
     Critical role of CD44 in hepatotoxin-mediated liver injury.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
119. KUROSAKI M , Matsunaga K, Hirayama I, Tanaka T, et al
     The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. LACKNER C , Gogg-Kamerer M, Zatloukal K, Stumptner C, et al
     Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. CACOUB P , Carrat F, Bedossa P, Lambert J, et al
     Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study - ANRS HC02.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. BOSCH J , Berzigotti A, Garcia-Pagan JC, Abraldes JG, et al
     The management of portal hypertension: Rational basis, available treatments and future options.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. CHALASANI N , Wilson L, Kleiner DE, Cummings OW, et al
     Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. ANGELI P , Merkel C
     Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2008
125. CARACENI P , Dazzani F, Salizzoni E, Domenicali M, et al
     Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. WATSON MR , Wallace K, Gieling RG, Manas DM, et al
     NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. POPOV Y , Patsenker E, Stickel F, Zaks J, et al
     Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. GOETZ M , Vieth M, Kanzler S, Galle PR, et al
     In vivo confocal laser laparoscopy allows real time subsurface microscopy in animal models of liver disease.
     J Hepatol. 2008;48:91-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2007
129. VALENTI L , Dongiovanni P, Fargion S, Fracanzani AL, et al
     Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles   
     
     
     
130. ZAMBRUNI A , Trevisani F, Di Micoli A, Savelli F, et al
     Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. GIOVANNA F , Bortolotti F, Francesco D
     Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. VIDALI M , Tripodi MF, Ivaldi A, Zampino R, et al
     Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. OGISO T , Nagaki M, Takai S, Tsukada Y, et al
     Granulocyte colony-stimulating factor impairs liver regeneration in mice through the up-regulation of interleukin-1beta.
     J Hepatol. 2007;47:816-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2007
134. WASMUTH HE , Zaldivar MM, Berres ML, Werth A, et al
     The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. LAFFI G , Tarquini R, Marra F
     Thrombocytopenia in chronic liver disease: lessons from transplanted patients.
     J Hepatol. 2007;47:625-9.
     PubMed     Text format     Related articles   
     
     
     
136. STADLBAUER V , Davies NA, Wright G, Jalan R, et al
     Endotoxin measures in patients' sample: how valid are the results?
     J Hepatol. 2007;47:726-7.
     PubMed     Text format     Related articles   
     
     
     
137. MOLLER HJ , Gronbaek H, Schiodt FV, Holland-Fischer P, et al
     Soluble CD163 from activated macrophages predicts mortality in acute liver failure.
     J Hepatol. 2007;47:671-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2007
138. TOYODA H , Kumada T, Kaneoka Y, Murakami Y, et al
     Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. POUSTCHI H , Negro F, Hui J, Cua IH, et al
     Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2007
140. MIURA K , Yoshino R, Hirai Y, Goto T, et al
     Epimorphin, a morphogenic protein, induces proteases in rodent hepatocytes through NF-kappaB.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. VIVARELLI M , Burra P, Barba GL, Canova D, et al
     Influence of steroids on HCV recurrence after liver transplantation: A prospective study.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. LAI M , Hyatt BJ, Nasser I, Curry M, et al
     The clinical significance of persistently normal ALT in chronic hepatitis B infection.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. KNIGHT B , Lim R, Yeoh GC, Olynyk JK, et al
     Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2007
144. SUN HC , Zhang W, Qin LX, Zhang BH, et al
     Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. IMERYUZ N , Tahan V, Sonsuz A, Eren F, et al
     Iron preloading aggravates nutritional steatohepatitis in rats by increasing apoptotic cell death.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2007
146. MELUM E , Friman S, Bjoro K, Rasmussen A, et al
     Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2007
147. GRESSNER OA , Lahme B, Demirci I, Gressner AM, et al
     Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: